
GLP-1 weight loss in Colorado
- Visit type
- No video visit required
- Licensing
- Colorado Medical Board
- Updated
- Licensed by
- Colorado Medical Board
- Telehealth
- No video visit required
- Semaglutide injections
- Available
- Tirzepatide injections
- Available
- Medicaid
- Limited coverage
- Shipping
- 2–3 business days
Colorado residents can now access GLP-1 medications like semaglutide and tirzepatide through telehealth — from Denver and the Front Range to mountain towns and the Western Slope. Pallas Health connects you with a board-certified provider licensed in Colorado who can evaluate your eligibility in under 5 minutes and, if appropriate, prescribe medication that ships to any Colorado address in a few business days. Compounded semaglutide is $139 first month, then $199 every 4 weeks; compounded tirzepatide is $179 first month, then $299 every 4 weeks.
How telehealth prescribing works in Colorado
Colorado permits licensed providers to use telehealth to establish a patient relationship and prescribe non-controlled medications like GLP-1s, including synchronous video and, in appropriate cases, asynchronous review when the standard of care is met.
Colorado requires any provider writing a prescription to a Colorado resident to hold an active Colorado medical license — out-of-state licensure is not sufficient. Under C.R.S. § 12-240-107 and Colorado Medical Board telehealth policy, licensed providers may use telemedicine to establish the provider-patient relationship and prescribe non-controlled medications, including via synchronous video and, in appropriate cases, asynchronous review when the standard of care is met. Colorado is also a full member of the Interstate Medical Licensure Compact (IMLC), which streamlines licensure for qualifying providers but does not waive the Colorado-license requirement to treat Colorado patients. Every Pallas clinician who treats Colorado patients is individually licensed by the Colorado Medical Board. GLP-1s are not controlled substances, so Colorado's separate Prescription Drug Monitoring Program and controlled-substance telemedicine requirements don't add friction here, but our providers still document a complete history, screen for contraindications like personal or family history of medullary thyroid carcinoma, and schedule follow-up visits to monitor response and titrate the dose.
Medicaid & insurance in Colorado
Health First Colorado (Colorado Medicaid) covers GLP-1s for type 2 diabetes with prior authorization. Coverage for weight-management indications is limited. Compounded GLP-1s are not covered. Pallas is a cash-pay telehealth service. Medicaid and private insurance do not apply to our prescriptions; pricing is flat and disclosed up front.
Simple cash-pay pricing in Colorado
No insurance, and the same price in every Colorado ZIP code. You see your full price during intake, before you pay anything. One plan price covers your US-licensed provider, check-ins, dose adjustments and care-team messaging, with no membership fee. Medication ships free, and nothing is charged until a clinician prescribes. Cancel anytime. Your clinician helps determine which option is appropriate for you.
Compounded
- Semaglutide injectionsFrom $139
- Tirzepatide injectionsFrom $179
Brand-name
- Wegovy® injectionsFrom $499
- Zepbound® injectionsFrom $499
- Ozempic® injectionsFrom $499
- Mounjaro® injections$1,099/mo
- Wegovy® pillFrom $299
- Foundayo™ pillFrom $299
Semaglutide and tirzepatide prices in Colorado, plan by plan
Semaglutide vs tirzepatide in Colorado
Both are once-weekly injections available to Colorado patients through Pallas, as compounded preparations and as the FDA-approved brand-name products. They work differently: semaglutide activates the GLP-1 receptor, while tirzepatide activates both the GLP-1 and GIP receptors — two of the gut hormones that regulate appetite and fullness.
In SURMOUNT-5, the head-to-head clinical trial of the FDA-approved products, Zepbound® (tirzepatide 10 mg or 15 mg weekly) produced greater average weight loss than Wegovy® (semaglutide 1.7 mg or 2.4 mg weekly) — 20.2% versus 13.7% of body weight over 72 weeks — with broadly similar tolerability. That trial predates Wegovy®'s higher 7.2 mg weekly dose, which reached 18.7% average weight loss over 72 weeks in the separate STEP UP trial; separate trials do not provide a direct comparison. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary.
Cost and track record differ too: compounded semaglutide renews at $199 every 4 weeks versus $299 for tirzepatide (full terms in the questions below), and semaglutide has the longer post-market record. Which medication fits your health history, goals, and budget is a decision you make with a clinician licensed in Colorado — our full semaglutide vs tirzepatide comparison covers the deeper differences.
Cities served in Colorado
Partner pharmacies ship to every ZIP code in Colorado, including:
- Denver
- Colorado Springs
- Aurora
- Fort Collins
- Lakewood
- Thornton
- Arvada
- Boulder
Prescription GLP-1s
Doctor-led GLP-1 weight loss care, shipped by a US-licensed pharmacy.
From $139/mo
Before
AfterColorado GLP-1 questions
Start the online intake (about 5 minutes). A Colorado-licensed clinician reviews it by secure message, and if a GLP-1 is appropriate, a US-licensed pharmacy ships it to you in 2–3 business days.
Same intake as semaglutide. If appropriate, a Colorado-licensed clinician can prescribe compounded tirzepatide or FDA-approved Zepbound® or Mounjaro®, and explains which fits you.
Yes. A Colorado-licensed clinician can prescribe it for you with a documented clinical reason, and a US-licensed compounding pharmacy prepares it per patient. Brand-name Wegovy® is also available.
Yes, once an NP finishes required mentorship hours; earlier, prescribing is still supervised. GLP-1s aren't controlled substances, so Colorado's added controlled-substance telemedicine rules don't apply.
Several do. Check that its clinicians are licensed in Colorado, that it uses US-licensed compounding pharmacies, and that it is LegitScript-certified. Pallas serves Colorado.
No. Colorado allows a licensed clinician to review your intake by secure message and prescribe without a scheduled video call. They may ask for a video visit only if your history calls for it.
Intake takes about 5 minutes, and a Colorado-licensed clinician usually reviews it within 1 to 2 business days. If prescribed, the pharmacy ships in 2–3 business days.
Yes. Partner pharmacies ship to every Colorado ZIP code, from Denver and Colorado Springs to the smallest towns, usually in 2–3 business days. Remote addresses may take an extra day.
Several do. Check that its clinicians hold a Colorado license, that it uses US-licensed pharmacies, and that it is LegitScript-certified (the database is public). Pallas serves Colorado.
Health First Colorado (Colorado Medicaid) covers GLP-1s for type 2 diabetes with prior authorization. Compounded GLP-1s are not covered. Pallas is cash-pay, so Medicaid rules do not apply.
One flat cash-pay price, the same in every Colorado ZIP code, no insurance needed. It covers your clinician, check-ins and messaging, and medication ships free once prescribed.
A Colorado-licensed clinician decides after reviewing your intake. GLP-1s are generally considered at a BMI of 30 or more, or 27 or more with a condition like high blood pressure.
Wegovy®, Ozempic®, Zepbound® and Mounjaro® are FDA-approved. Compounded semaglutide and tirzepatide are made per patient by US-licensed pharmacies and are not FDA-approved. Your clinician decides.
Yes. Tell your clinician your current medication, dose and everything else you take during intake. If appropriate, they continue you at a comparable dose. Don't change a prescription on your own.
Most patients use a once-weekly injection with a very fine needle. A daily tablet is available on request. Your clinician confirms which form is appropriate for you.
Mostly stomach-related: nausea, constipation or diarrhea, usually mildest when the dose is raised slowly. They are avoided in pregnancy and with a personal or family history of medullary thyroid cancer or MEN2.
You answer health questions online in about 5 minutes. A Colorado-licensed clinician reviews it by secure message, and if a GLP-1 is appropriate, a licensed pharmacy ships it in 2–3 business days.
Your first order arrives in 2–3 business days, and most patients start low and step up gradually. Your plan renews on a set schedule so refills arrive before you run out; change or cancel anytime in the portal.
Compounded semaglutide injections are $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. Your clinician, check-ins and messaging are included; shipping is free.
Compounded tirzepatide injections are $179 first month, then $299 every 4 weeks, charged once a clinician prescribes. Cancel anytime. Your clinician, check-ins and messaging are included; shipping is free.
Yes. Wegovy®, Zepbound® and Foundayo™ are FDA-approved for weight management, Ozempic® and Mounjaro® for type 2 diabetes. All are cash-pay: pens from $499 first month, daily pills from $299.
Health First Colorado (Colorado Medicaid) covers GLP-1s for type 2 diabetes with prior authorization. Compounded GLP-1s are not covered. Pallas is cash-pay, so Medicaid rules do not apply.
Two cash-pay paths: stay on Wegovy® or Zepbound® from $499 first month, or a compounded plan from $139 first month if a licensed clinician finds it appropriate. Tell your clinician your current dose.
A decision for you and your clinician. Semaglutide costs less and has the longer track record; tirzepatide acts on two gut-hormone receptors instead of one. The comparison above covers the trials.
Pallas serves all of Colorado with one price for compounded semaglutide: $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. No video visit is required.
More states
Rule changes affecting Colorado
- 2026-07-27 Correction — statute and rule citations updated on four state pages: Vermont now cites 18 V.S.A. § 9361(b) (previously a nonexistent § 3053a), Ohio cites Ohio Rev. Code § 4743.09 and OAC 4731-37-01 (previously the controlled-substances chapter 4731-11), Colorado cites C.R.S. § 12-240-107 (previously § 12-240-138, the professional-entities section), and Alabama cites Ala. Code §§ 34-24-701 through 34-24-707 (previously the repealed Admin. Code ch. 540-X-15). Regulatory substance is unchanged in all four.State statute and administrative-code databases; surfaced by our automated source check (PR #45).
From our state-by-state rules tracker. Get an email when a rule changes.
Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.







